A Multiple Modality Approach for Targeting Chemotherapy-and Parpi-Resisatnt Ovarian Cancer

CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer

J Xuan, RB Pearson, E Sanij

2020-11-01

Acquired drug resistance leads to poor clinical outcome in high grade serous ovarian cancer (HGSOC). We have demonstrated the effi..